| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Revenues | 0 | 0 | - | - |
| Selling, general and administrative expenses | 207,845 | 187,373 | 326,018 | 339,457 |
| Research and development | 25,334 | 80,983 | 65,885 | 65,720 |
| Total operating expenses | 233,179 | 268,356 | 391,903 | 405,177 |
| Loss from operations | -233,179 | -268,356 | -391,903 | -405,177 |
| Loss on settlement of debt | - | - | 115,085 | - |
| Interest expense - related party | - | - | 19,231 | 19,231 |
| Interest expense | 30,684 | 25,100 | 7,613 | 7,613 |
| Interest expense - related party | 21,731 | 21,731 | - | - |
| Gain (loss) on settlement of debt | 0 | 0 | - | - |
| Total other income (expenses) | -52,415 | -46,831 | 88,241 | -26,844 |
| Net (loss) | - | - | -303,662 | - |
| Net loss | -285,594 | -315,187 | - | -432,021 |
| Basic eps | - | - | - | 0 |
| Basic and diluted | 0 | 0 | - | - |
| Weighted average number of shares outstanding | 257,809,759 | 257,139,815 | 248,614,744 | 247,717,837 |
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)